Genitourinary Cancer,Prostate Cancer Overall Survival of Abi+Ola vs. Abi+Pbo in 1st Line mCRPC Mar 27, 2023
Genitourinary Cancer,Prostate Cancer Darolutamide vs. Docetaxel for Treating mHSPC by Disease Volume and Risk Mar 27, 2023
Genitourinary Cancer,Prostate Cancer First-Line mCRPC Therapy After Apa Treatment Progression in Patients Mar 27, 2023
Genitourinary Cancer,Prostate Cancer Rucaparib for Metastatic Prostate Cancer: Promising rPFS Treatment Results Mar 27, 2023
Bladder Cancer,Genitourinary Cancer CheckMate 274 Trial: Adjuvant Nivolumab vs Placebo in MIUC Analysis Mar 14, 2023
Bladder Cancer,Genitourinary Cancer JAVELIN Bladder 100: Avelumab for Advanced UC in Subgroups Mar 14, 2023
Genitourinary Cancer,Popular,RCC (Renal Cell Carcinoma) CheckMate 214 Study: Clinical Efficacy of NIVO+IPI in sRCC Patients Feb 27, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) CheckMate 9ER Trial: Cabozantinib and Nivolumab Combination Therapy for Advanced RCC Feb 27, 2023
